On CK2 regulation of chronic lymphocytic leukemia cell viability

Molecular and Cellular Biochemistry

Volumn 356, Issue 1-2, 2011, Pages 51-55

  Martins, Leila R ^a   Lúcio, Paulo ^b   Silva, Milene C ^a   Gameiro, Paula ^b   Silva, Maria G ^b   Barata, João T ^a  

^a INSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES   (Portugal)

^b INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

Chronic lymphocytic leukemia; CK2; IgM; OP9 co culture; PI3K PTEN; Signaling therapy

Indexed keywords

BETA 2 MICROGLOBULIN; CASEIN KINASE II; PROTEIN KINASE ZAP 70; PROTEIN SERINE THREONINE KINASE INHIBITOR;

APOPTOSIS; ARTICLE; BLOOD; CELL SURVIVAL; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; LYMPHOCYTE; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; STROMA CELL; UPREGULATION;

ANIMALS; CASEIN KINASE II; CELL SEPARATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKOCYTES, MONONUCLEAR; MICE; PROTEIN KINASE INHIBITORS;

EID: 84855239481     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0947-6     Document Type: Article

References (19)

1. Zenz T, Mertens D, Kuppers R, Dohner H, Stilgenbauer S (2010) From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat Rev Cancer 10:37-50. doi:10.1038/nrc2764
2. Gribben JG, O'Brien S (2011) Update on therapy of chronic lymphocytic leukemia. J Clin Oncol 29:544-550. doi:10.1200/JCO.2010. 32.3865
3. Barata JT (2011) The impact of PTEN regulation by CK2 on PI3K-dependent signaling and leukemia cell survival. Adv Enzyme Regul 51:37-49. doi:10.1016/j.advenzreg.2010.09.012
4. Silva A, Yunes JA, Cardoso BA, Martins LR, Jotta PY, Abecasis M, Nowill AE, Leslie NR, Cardoso AA, Barata JT (2008) PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability. J Clin Investig 118:3762-3774. doi:10.1172/JCI34616
5. Silva A, Jotta PY, Silveira AB, Ribeiro D, Brandalise SR, Yunes JA, Barata JT (2010) Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2- and gamma-secretase inhibitors. Haematologica 95:674-678. doi:10.3324/haematol.2009.011999
6. Kim JS, Eom JI, Cheong JW, Choi AJ, Lee JK, Yang WI, Min YH (2007) Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia. Clin Cancer Res 13:1019-1028. doi:10.1158/1078-0432.CCR-06-1602 (Pubitemid 46340381)
7. Ringshausen I, Schneller F, Bogner C, Hipp S, Duyster J, Peschel C, Decker T (2002) Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta. Blood 100:3741-3748. doi:10.1182/blood-2002-02-0539 (Pubitemid 35303946)
8. Martins LR, Lucio P, Silva MC, Anderes KL, Gameiro P, Silva MG, Barata JT (2010) Targeting CK2 overexpression and hyperactivation as a novel therapeutic tool in chronic lymphocytic leukemia. Blood 116:2724-2731. doi:10.1182/blood- 2010-04-277947
9. Deglesne PA, Chevallier N, Letestu R, Baran-Marszak F, Beitar T, Salanoubat C, Sanhes L, Nataf J, Roger C, Varin-Blank N, Ajchenbaum-Cymbalista F (2006) Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of Zap70 expression. Cancer Res 66:7158-7166. doi:10.1158/0008-5472.CAN-06-0085 (Pubitemid 44197694)
10. Shehata M, Schnabl S, Demirtas D, Hilgarth M, Hubmann R, Ponath E, Badrnya S, Lehner C, Hoelbl A, Duechler M, Gaiger A, Zielinski C, Schwarzmeier JD, Jaeger U (2010) Reconstitution of PTEN activity by CK2 inhibitors and interference with the PI3-K/Akt cascade counteract the antiapoptotic effect of human stromal cells in chronic lymphocytic leukemia. Blood 116:2513-2521. doi:10.1182/blood-2009-10-248054
11. Slaton JW, Unger GM, Sloper DT, Davis AT, Ahmed K (2004) Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model. Mol Cancer Res 2:712-721
12. Herishanu Y, Perez-Galan P, Liu D, Biancotto A, Pittaluga S, Vire B, Gibellini F, Njuguna N, Lee E, Stennett L, Raghavachari N, Liu P, McCoy JP, Raffeld M, Stetler-Stevenson M, Yuan C, Sherry R, Arthur DC, Maric I, White T, Marti GE, Munson P, Wilson WH, Wiestner A (2011) The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 117:563-574. doi:10.1182/blood-2010-05-284984
13. Ghia P, Chiorazzi N, Stamatopoulos K (2008) Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation. J Intern Med 264:549-562. doi:10.1111/j.1365-2796.2008.02030.x
14. Quiroga MP, Balakrishnan K, Kurtova AV, Sivina M, Keating MJ, Wierda WG, Gandhi V, Burger JA (2009) B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406. Blood 114:1029-1037. doi: 10.1182/blood-2009-03-212837
15. Seiffert M, Stilgenbauer S, Dohner H, Lichter P (2007) Efficient nucleofection of primary human B cells and B-CLL cells induces apoptosis, which depends on the microenvironment and on the structure of transfected nucleic acids. Leukemia 21:1977-1983. doi:10.1038/sj.leu.2404863 (Pubitemid 47299973)
16. Petlickovski A, Laurenti L, Li X, Marietti S, Chiusolo P, Sica S, Leone G, Efremov DG (2005) Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells. Blood 105:4820-4827. doi: 10.1182/blood-2004-07-2669 (Pubitemid 40807309)
17. Cuni S, Perez-Aciego P, Perez-Chacon G, Vargas JA, Sanchez A, Martin-Saavedra FM, Ballester S, Garcia-Marco J, Jorda J, Durantez A (2004) A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells. Leukemia 18:1391-1400. doi:10.1038/sj.leu. 2403398 (Pubitemid 39136749)
18. Plate JM (2004) PI3-kinase regulates survival of chronic lymphocytic leukemia B-cells by preventing caspase 8 activation. Leuk Lymphoma 45:1519-1529. doi:10.1080/10428190410001683642 (Pubitemid 38885993)
19. Weinberg JB, Volkheimer AD, Chen Y, Beasley BE, Jiang N, Lanasa MC, Friedman D, Vaccaro G, Rehder CW, Decastro CM, Rizzieri DA, Diehl LF, Gockerman JP, Moore JO, Goodman BK, Levesque MC (2007) Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia. Am J Hematol 82:1063-1070. doi:10.1002/ajh.20987 (Pubitemid 350209847)